{"symbol":"BSX","fiscalQuarter":"Q3-2016","reportDate":"2016-10-26","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q3-2016","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 1.56%","keyNumbers":[{"metric":"EPS","actual":"$0.27","expected":"N/A","surprise":"+1.12%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management expressed confidence in the company's long-term growth strategy.","They highlighted ongoing investments in innovation and product development."],"summary":"Overall, management remains focused on strategic initiatives to drive future growth. However, they did not provide specific guidance for upcoming quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a small beat on EPS, which indicates some positive momentum. However, the stock fell by 1.56% in reaction, likely due to the lack of revenue details and forward guidance. Investors may be cautious as they await more concrete information on the company's performance and strategy moving forward.","metaDescription":"Boston Scientific (BSX) Q3 2016 earnings: EPS beat by 1.12%. Stock down 1.56%. Full breakdown."}}